Verrica Pharmaceuticals buy Needham & Company LLC
Start price
14.05.24
/
50%
€9.90
Target price
14.05.25
€14.81
Performance (%)
-95.10%
End price
15.05.25
€0.48
Summary
This prediction ended on 15.05.25 with a price of €0.48. Massive losses of -95.10% were the result for the BUY prediction by Needham___Company_LL. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Verrica Pharmaceuticals | - | - | - |
| iShares Core DAX® | 0.734% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -2.686% | -0.146% | 3.810% |
| iShares Nikkei 225® | -2.261% | -2.729% | 11.679% |
| iShares S&P 500 | -1.346% | 0.467% | 1.970% |
Comments by Needham___Company_LL for this prediction
In the thread Discuss Verrica Pharmaceuticals
Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) had its price target raised by analysts at Needham & Company LLC from $8.00 to $16.00. They now have a "buy" rating on the stock.
Ratings data for VRCA provided by MarketBeat
In the thread Trading Verrica Pharmaceuticals
Die von Needham___Company_LL gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Needham___Company_LL for Verrica Pharmaceuticals
Verrica Pharmaceuticals
Start price
Target price
Perf. (%)
€2.62
15.08.24
15.08.24
€10.95
15.08.25
15.08.25
-77.18%
16.08.25
16.08.25
Verrica Pharmaceuticals
Start price
Target price
Perf. (%)
€2.74
10.11.23
10.11.23
€7.49
10.11.24
10.11.24
-71.24%
11.11.24
11.11.24
Verrica Pharmaceuticals
Start price
Target price
Perf. (%)
€3.90
23.08.23
23.08.23
€9.25
23.08.24
23.08.24
-38.46%
24.08.24
24.08.24